Enzyme-based artificial organs are being developed as metabolic assist devices. These are required when normal metabolism is impaired, or when the body is overloaded by undesired metabolites or toxins. The implementations of this approach for treating a genetic disease, and for metabolic support in liver failure are envisaged. The kinetic aspects and mass transfer characteristics of bioreactors for these systems are considered in detail.
SidemanS., ChangT.M.S., Eds Hemoperfusion: Kidney and liver support and detoxification, (McGraw-Hill, New York, 1980).
8.
ChangT.M.S. Ed. Biomedical applications of immobilized enzymes. Vols I and II. (Plenum, New York, 1976).
9.
TegtmeierF., BrunnerG.Enzymic detoxification using lipophilic hollow-fiber membranes.Artif Organs1985; 9: 37–41.
10.
GrynspanE., GrunfeldH., BrunnerG., SidemanS., LotanN.Heterogeneous phase enzymic bioreactors for blood treatment, in Therapeutic plasma exchange and selective plasma separation, JutzlerG.A., BambauerR., Eds (in press, 1985).
11.
GrynspanE., LotanN., SidemanS., KernerB., BrunnerG.Enzyme based metabolic assist systems.Trans ASAIO (in press, 1985).
12.
HalwachsW., VölkelW., BrunnerG., SchügerlK.Liquid membrane enzyme reactor for artificial liver support; in Brunner and Schmidt, Artificial liver support, pp. 219–229 (Springer, Berlin, 1981).
13.
SchmerG., NewmanM.L., RastelliL., DennisM.B.Jr, HenneW.Synthesis of enzyme reactors consisting of xenocells.Trans ASAIO1981; 27: 544–6.
14.
ChangT.M.S.Methods for the therapeutical applications of immobilized enzymes; in Mosbach, immobilized enzymes, Vol. 44 in Methods in Enzymology Series, pp. 676–698 (Academic Press, New York, 1976).
